Mount Lucas Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-19,431	Closed	-$54K	–	125
2017 Q2	$54K	Hold	19,431	–	–	0.01%	138
2017 Q1	$59K	Buy	19,431 +6,286	+48%	+$19.1K	0.01%	131
2016 Q4	$42K	Buy	13,145 +572	+5%	+$1.83K	0.01%	136
2016 Q3	$43K	Buy	+12,573	New	+$43K	0.01%	142